Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory

We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on Options Coach’s Substack by Taylor Selden. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc.'s share was trading at $547.93 as of July 16^th. REGN’s trailing and forward P/E were 13.93 and 15.29 respectively according to Yahoo Finance.

[caption id="attachment_1218522" align="aligncenter" width="768"] A research scientist studying a microscope in a discovery lab to develop new immunomedicines.[/caption]

Regeneron (REGN) presents a compelling asymmetric opportunity...